Showing 1 - 10 of 5,240
Physicians commonly receive marketing-related transfers from drug firms. We examine the impact of these relationships … fading out within a year. A marketing payment also leads physicians to begin treating cancer patients with lower expected …
Persistent link: https://www.econbiz.de/10014528376
We ask how competition influences the prescribing practices of physicians. Law changes granting nurse practitioners … variation in competition. In response, we find that general practice physicians (GPs) significantly increase their prescribing …. Our findings are consistent with a simple model of physician behavior in which competition for patients leads physicians …
Persistent link: https://www.econbiz.de/10013537781
effectiveness of these incentives, however, depends both on physicians' price sensitivity and their knowledge of patient prices. We … information. Applying this model to diabetes care, we find that physicians lack detailed price information and are more price …-elastic than full-information models imply. We predict that providing physicians detailed information on prices at the point of …
Persistent link: https://www.econbiz.de/10014468214
: the number of physicians in the physician's group (if any); the physician's integration with or employment by a hospital … or hospital system; and the average age of the other physicians in the physician's group. We present three key findings …. First, all else held constant, group physicians prescribe far fewer opioids, and prescribe them more appropriately, than do …
Persistent link: https://www.econbiz.de/10014421210
Persistent link: https://www.econbiz.de/10012194969
We study cartels that operated in the US generic drug industry, leveraging quarterly Medicaid data from 2011-2018 and a difference-in-differences approach comparing the evolution of prices of allegedly collusive drugs with a group of competitive control drugs. Our analysis highlights (i) the...
Persistent link: https://www.econbiz.de/10012670921
In agreements settling patent challenges in the drug industry, the plaintiff brand commonly licenses the defendant generic to sell prior to patent expiry. Some agreements require the generic to pay the brand royalties. Despite the superficial flow of profits, royalty terms may function as part...
Persistent link: https://www.econbiz.de/10014247939
The United States spends twice as much per person on pharmaceuticals as European countries, in large part because … reference countries. We estimate a structural model of demand and supply for pharmaceuticals in the US and reference countries …
Persistent link: https://www.econbiz.de/10013210081
targeted towards physicians at these hospitals. We find that the effects of price regulation on pharmaceutical firm effort … physicians, we observe that physicians receive 12% fewer promotional payments after their hospitals take up the program. The …
Persistent link: https://www.econbiz.de/10014512103
branded pharmaceuticals. We then present a theoretical framework for the pricing of branded pharmaceuticals, without and then …
Persistent link: https://www.econbiz.de/10014191301